0001193125-12-354977.txt : 20120814 0001193125-12-354977.hdr.sgml : 20120814 20120814134256 ACCESSION NUMBER: 0001193125-12-354977 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20120814 DATE AS OF CHANGE: 20120814 EFFECTIVENESS DATE: 20120814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BROOKSIDE CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001156175 IRS NUMBER: 043517087 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06625 FILM NUMBER: 121031466 BUSINESS ADDRESS: STREET 1: JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-516-2000 MAIL ADDRESS: STREET 1: JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 d387947d13fhr.txt FORM 13-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2012 Check here if Amendment [ ]; Amendment Number: ------------- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Brookside Capital Management, LLC* Address: John Hancock Tower 200 Clarendon Street Boston, Massachusetts 02116 Form 13F File Number: 28-06625 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: William E. Pappendick IV Title: Managing Director Phone: (617) 516-2000 Signature, Place, and Date of Signing: /s/ William E. Pappendick IV Boston, MA 8/14/2012 ---------------------------- ------------ --------- [Signature] [City, State] [Date] * Brookside Capital Management, LLC is the general partner of Brookside Capital Investors, L.P., which is the general partner of Brookside Capital Partners Fund, L.P. Brookside Capital Management, LLC is also the general partner of Brookside Capital Investors II, L.P., which is the general partner of Brookside Capital Trading Fund, L.P. Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s). Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 43 Form 13F Information Table Value Total: 3,726,856 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 28-06924 Brookside Capital Investors, L.P. 2 28-06946 Brookside Capital Partners Fund, L.P. 3 28-13491 Brookside Capital Trading Fund, L.P. 4 28-13492 Brookside Capital Investors II, L.P. BROOKSIDE CAPITAL MANAGEMENT, LLC FORM 13F INFORMATION TABLE AS OF 06/30/2012
Voting Title of Invesment Other Authority NAME OF ISSUER Class Cusip Market Value Long SHARES Discretion Managers Sole Shared None ACHILLION PHARMACEUTICALS IN COM 00448Q201 10,101,083.40 1,629,207.00 X AKAMAI TECHNOLOGIES INC COM 00971T101 178,747,483.50 5,629,842.00 X ALLOT COMMUNICATIONS LTD SHS M0854Q105 43,083,400.50 1,546,425.00 X AMARIN CORP PLC ADR 23111206 70,244,033.82 4,857,817.00 X AMERICAN CAPITAL AGENCY CORP COM 02503X105 111,977,832.02 3,331,682.00 X ANHEUSER BUSCH INBEV SA/NV SPONSORED ADR 03524A108 88,731,931.95 1,114,023.00 X AOL INC COM 00184X105 47,837,761.92 1,703,624.00 X APPLE INC COM 37833100 304,930,928.00 522,142.00 X BRIGHTCOVE INC COM 10921T101 7,961,332.48 520,008.00 X BROADCOM CORP CL A 111320107 28,475,817.28 843,478.00 X CELGENE CORP COM 151020104 83,369,183.20 1,299,395.00 X CHECK POINT SOFTWARE TECH LT ORD M22465104 35,240,538.42 710,638.00 X CTRIP COM INTL LTD AMERICAN DEP SHS 22943F100 120,217,954.84 7,172,909.00 X CVS CAREMARK CORPORATION COM 126650100 77,898,910.00 1,667,000.00 X DIRECTV COM CL A 25490A101 125,409,060.10 2,568,805.00 X DOLLAR GEN CORP NEW COM 256677105 201,520,389.00 3,705,100.00 X EASTMAN CHEM CO COM 277432100 65,994,673.26 1,310,198.00 X EATON CORP COM 278058102 66,079,299.78 1,667,406.00 X E M C CORP MASS COM 268648102 241,607,089.90 9,426,730.00 X GOLAR LNG LTD BERMUDA SHS G9456A100 59,810,182.90 1,586,477.00 X GOOGLE INC CL A 38259P508 108,777,626.75 187,525.00 X HOME INNS & HOTELS MGMT INC SPON ADR 43713W107 27,681,546.64 1,221,604.00 X IDENIX PHARMACEUTICALS INC COM 45166R204 112,951,500.00 10,987,500.00 X KINDER MORGAN INC DEL COM 49456B101 205,007,386.14 6,362,737.00 X KINDER MORGAN INC DEL *W EXP 05/25/201 49456B119 44,336,559.60 20,526,185.00 X KOHLS CORP COM 500255104 103,731,483.86 2,280,314.00 X MAP PHARMACEUTICALS INC COM 56509R108 44,842,913.70 2,999,526.00 X MEAD JOHNSON NUTRITION CO COM 582839106 71,427,103.33 887,183.00 X MICHAEL KORS HLDGS LTD SHS G60754101 73,464,303.76 1,755,839.00 X MONSANTO CO NEW COM 61166W101 247,790,009.68 2,993,356.00 X NEOPHOTONICS CORP COM 64051T100 617,500.00 125,000.00 X OPENTABLE INC COM 68372A104 41,949,320.00 932,000.00 X PARAMETRIC TECHNOLOGY CORP COM NEW 699173209 63,198,047.04 3,015,174.00 X RED HAT INC COM 756577102 72,122,361.92 1,276,954.00 X SANDERSON FARMS INC COM 800013104 33,120,941.18 722,849.00 X SPLUNK INC COM 848637104 281,000.00 10,000.00 X TEXTRON INC COM 883203101 57,437,265.00 2,309,500.00 X TRANSDIGM GROUP INC COM 893641100 145,723,692.30 1,085,061.00 X VERIFONE SYS INC COM 92342Y109 88,937,746.77 2,687,753.00 X VERTEX PHARMACEUTICALS INC COM 92532F100 129,351,348.00 2,313,150.00 X VMWARE INC CL A COM 928563402 41,623,488.00 457,200.00 X YANDEX N V COM N97284108 2,857,500.00 150,000.00 X YOUKU INC SPONSORED ADR 98742U100 40,386,739.76 14,350,762.00 *** X
*** Ownership represents 1,862,857 ADS plus 224,782,288 ordinary shares convertible to ADS on an 18:1 basis***